Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01562340 · ClinicalTrials.gov registry record · NA
Pomegranate and Hemodialysis Pilot Trial
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01562340 is a NA study that has completed, run by University of Washington. The registered enrollment target is 24 participants.
The verdict
NCT01562340, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
In this study, the investigators will administer pomegranate juice or fruit extract as a targeted antioxidant therapy to hemodialysis patients. The investigators will examine whether these pomegranate products will be safe and well-tolerated. The investigators will also examine whether these products may lead to improvements in blood serum biomarkers of: * oxidative stress status * inflammatory status * endothelial dysfunction
Interventions
- OTHER Pomegranate juice
- OTHER Pomegranate fruit extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01562340
The ClinicalTrials.gov registry entry for NCT01562340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pomegranate juice is the first listed.
NCT01562340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01562340 about?
NCT01562340 is a clinical study titled "Pomegranate and Hemodialysis Pilot Trial". In this study, the investigators will administer pomegranate juice or fruit extract as a targeted antioxidant therapy to hemodialysis patients. The investigators will examine whether these pomegranate products will be safe and well-tolerated. The investigators will also examine whether these produc...
What is the current status of trial NCT01562340?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01562340?
The interventions under investigation include: Pomegranate juice (OTHER), Pomegranate fruit extract (OTHER).
Who is sponsoring clinical trial NCT01562340?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.